Navigation Links
ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives
Date:5/21/2008

MINNEAPOLIS, May 21 /PRNewswire/ -- ACM today announced a new strategic alignment that will focus the company's business development efforts on providing next generation technology and services to the two most critical markets influencing the delivery of healthcare today: commercial plans and payers, and federal and state governments.

Executive Vice-President of Business Development Gary Loeber has been named EVP/General Manager for Government, and will focus his team on reaching out to those decision makers at the federal and state level providing benefits to the nearly 100 million Americans enrolled in Medicaid and Medicare programs. In addition to this new responsibility, Gary will continue to oversee ACM's PrepPoint(R) program, pharmacy benefit management (PBM) clients, and other services provided to the pharmaceutical industry.

Glen Udine, Vice-President of Account Management, has been promoted to EVP/General Manager for Commercial and, with his experienced sales and account team, will continue to support ACM's existing group of highly-satisfied customers. The Commercial team also will lead all business development efforts with health plans, and other payers or strategic partners in the commercial segment.

"We are very excited about this new organizational structure that aligns the best of our talented staff in the areas where they can deliver the greatest benefits to our current and future clients," David J. McLean, Ph.D., ACM's Chief Executive Officer said. "Particularly in the government sector, the need has never been greater for value-driven electronic services to manage injectable pharmaceuticals. With ACM's 13 year track record of experience and success in re-pricing medical pharmacy claims and providing the very latest prior authorization decision support tools, we can lead the way in delivering what it takes to impact both the cost and quality of care in America."

About ACM

A healthcare benefits management comp
'/>"/>

SOURCE ACM
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy
2. Best Practices Insurance Services Announces Key Additions to Senior Management
3. DATATRAK Announces Restructured Senior Management Team
4. David M. Boitano Promoted to Senior Vice President
5. UPMC for Life is Pennsylvania Sponsor for National Senior Health & Fitness Day
6. Varenna Translates Resort Living Into Everyday Senior Living
7. RPS Enhances Clinical Expertise and Leadership with Two Additions to Senior Management Team
8. New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
9. New Studies of Bush Administration $770 Million SNF Medicare Cut Find Seniors Care Jeopardized, Local Jobs Lost, National and State Economies Threatened
10. Blue Cross Blue Shield of Michigan Seeking Nominations for Outstanding Senior Advocates
11. Geriatrician finds seniors gait a sign of whats to come
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have been awarded two-year grants for their work on ... Of the 110 initial submissions to the new Novo ... four projects were funded, three of which are led ... Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., ... will use his $500,000 proof of principle grant to ...
(Date:4/18/2014)... release is available in French . ... revolutionize surgical practice and regenerative medicine. A team led ... Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the ... 13), has just demonstrated that the principle of adhesion ... vivo to repair soft-tissue organs and tissues. This easy-to-use ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... ... producer of information resources for senior healthcare executives, today announced that HealthLeaders Magazine ... Healthcare Publication Editors. , ... MARBLEHEAD, MA (PRWEB) May 4, 2010 -- HealthLeaders Media, ...
... should not abandon them , TUESDAY, May 4 (HealthDay News) ... Monday it was investigating possible links between widely used hormonal ... diabetes and heart disease, thousands of men who rely on ... to do next. , According to experts, the main advice ...
... , ... Episencial and the Green Your School Grant ... $2,250 in cash and products to fund student-related projects that teach ... health of preschoolers by reducing their exposure to unnecessary and potentially ...
... be an effective preventive measure, researchers say , TUESDAY, May ... be one way to slow the HIV/AIDS epidemic, according to ... greater risk for HIV infection than those not infected with ... 18 to 24, who were uncircumcised, did not have HIV ...
... University have found that colonoscopy preparation drugs administered the ... those given the night before and the morning of ... effects such as abdominal pain, sleep loss and workday ... results between 116 colonoscopy patients given a split dosage ...
... An enchanted estate set ... escape, in total peace. , , ... 1, 2010 -- What is Euterpini? , , ,Eight typical local villas, the so-called dammusi, that sleep ... western side of the island of Pantelleria , and named after local plants and flowers found ...
Cached Medicine News:Health News:HealthLeaders Magazine Named Publication of the Year – ASHPE's Most Prestigious Award 2Health News:HealthLeaders Magazine Named Publication of the Year – ASHPE's Most Prestigious Award 3Health News:As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution 2Health News:As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution 3Health News:Preschools: Apply Now for the “Green Your School Grant” from Episencial 2Health News:Preschools: Apply Now for the “Green Your School Grant” from Episencial 3Health News:Preschools: Apply Now for the “Green Your School Grant” from Episencial 4Health News:Preschools: Apply Now for the “Green Your School Grant” from Episencial 5Health News:Men With HPV at Higher Risk for HIV, Study Finds 2Health News:Study finds cutting colonoscopy preparation from 2 days to 1 day just as effective 2
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... for Advanced Drug Delivery Systems -- Focus ... STUDY OBJECTIVES ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Samadi, Vice Chairman, Department Urology, and Chief of Robotics and Minimally ... City , expressed concern today regarding the conclusions of a study ... ( BMJ ).  Following a group of 9,000 men for ... every three years, with the rest functioning as a control, ...
... April 14, 2011 Ron Van Beek , ... , announced that research conducted at Iowa State University ... DiaGel eliminates bacteria on contact. Axaphen ... disk diffusion, and traditional microbiological plating.  Through this work, ...
Cached Medicine Technology:Does Prostate Cancer Screening Reduce Mortality Rates? 2Does Prostate Cancer Screening Reduce Mortality Rates? 3Does Prostate Cancer Screening Reduce Mortality Rates? 4Van Beek Natural Science's Patented Active Compound in DiaGel Offers one Dose Natural Cure for Pet Bacterial Diarrhea 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: